Muireann joined us just over 3 and a half years ago and has played an important role in our investment team, working on deals including Kyte, NWP, Vyta and Innopharma, as well as the ongoing management of Schivo.  She took her first Board seat on the recent completion of our Innopharma investment and has built a strong relationship with management. To add to this, she has also taken the ESG lead role in the Dublin team.

Emma joined us in November 2022 and has made a very strong contribution to the team, including the successful completion of Innopharma.

Neil McGowan, Partner and co-Head of Investments, commented:

“It’s been a pleasure to witness the progress that both Muireann and Emma have made in recent years, with both of them becoming integral members of the team and making significant contributions to our work.” 

Many congratulations, Muireann and Emma.